Search Results

About Beyfortus™ (Nirsevimab) Beyfortus™ or Nirsevimab is a monoclonal antibody that is used to prevent respiratory syncytial virus (RSV) infection. It is administered intramuscularly as a one-time, fixed dose of 50mg (infants 5kg, or 100mg (infants ≥ 5 kg) during the RSV season. In October of 2003, the Nova...

Standard Operating Procedures (SOP's) Section 1: General REB SOP 101 - Introduction REB SOP 102 - Glossary REB SOP 103 - Terms of Reference REB SOP 104 - Activities Requiring REB Review REB SOP 105 - SOP Policy Development and Maintenance Section 2: REB Organization REB SOP 201 - Duties...

The Translating Research into Care (TRIC) Healthcare Improvement Research Program was established in 2013 at the IWK Health Centre and the QEII Health Sciences Centre to support Implementation Science*, which aims to incorporate new findings into practice. Projects will yield strong evidence and facilitate the translation of clinical science into...

Our Team Maritime Newborn Screening consists of a core team of people at the IWK who collaborate with a large network of hospitals (laboratories and clinics), healthcare providers, and specialty teams across the Maritimes. Core Team Betty-Ann O'Hearn – Administrative Assistant Pronouns: she/her Betty-Ann provides administrative support to Maritime Newborn...

Français What is Newborn Screening? Newborn screening involves routine tests recommended for all babies. Between 24-48 hours of life a few drops of blood are collected from a baby’s heel and spotted on a special piece of absorbent paper called a blotter. The blotters are tested for 28 rare, treatable...